Skip to main content

The Future of Dialysis: 8% Growth Driven by CKD, ESRD, and Technological Advances

 

The dialysis market is projected to grow at a CAGR of approximately 8% during the forecast period. This growth is driven by the increasing prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD), a growing geriatric population, rising adoption of home dialysis systems, and advancements in dialysis technology. However, high treatment costs and limited access to dialysis facilities in rural and underdeveloped regions pose significant challenges to market growth.

Dialysis is a medical procedure designed to remove waste products, toxins, and excess fluids from the blood in patients whose kidneys no longer function adequately. It is a life-saving treatment often used for patients with chronic kidney diseases or acute kidney injuries. The two primary forms of dialysis are hemodialysis, which filters blood through a machine, and peritoneal dialysis, which uses the peritoneum as a natural filter. Dialysis enables patients to manage their kidney failure and maintain a better quality of life.

Click here Click here to get PDF sample report:

 https://meditechinsights.com/dialysis-market/request-sample/ 

Growing Prevalence of CKD and ESRD: The Primary Driver of Dialysis Market Expansion

The rising prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD) is the most significant factor driving the dialysis market. CKD is becoming more widespread due to ageing populations, lifestyle-related conditions like diabetes and hypertension, and higher diagnostic awareness. As kidney failure becomes more common, the demand for life-sustaining dialysis treatments escalates. Moreover, the increasing global burden of non-communicable diseases directly contributes to the number of patients requiring dialysis. For instance, diabetes—a leading cause of kidney failure—is growing rapidly worldwide. Governments and healthcare systems are also prioritizing CKD management, which further accelerates market growth.

Home-Based Dialysis Systems: Transforming Patient Care Through Innovation

The adoption of home-based dialysis systems is significantly boosting the market by addressing convenience and patient comfort. Innovations such as automated peritoneal dialysis (APD) systems and portable hemodialysis devices have revolutionized patient care. These advancements enable individuals to undergo treatment in the comfort of their homes, reducing dependency on dialysis centers. Home-based solutions not only lower logistical and operational costs but also minimize hospital visits, which became particularly critical during the COVID-19 pandemic. Additionally, remote monitoring technologies integrated with these systems allow healthcare providers to track patient progress in real-time, enhancing treatment outcomes. This shift toward patient-centric, technology-driven solutions reflects a transformative approach in dialysis care, making treatments more accessible and tailored to individual needs.

Competitive Landscape Analysis

The global dialysis market is marked by the presence of established and emerging market players such as Baxter; B. Braun SE; Fresenius Medical Care AG; Medtronic; Asahi Kasei Medical Co., Ltd.; Nipro Corp.; DaVita; Becton, Dickinson and Company; Nikkiso Co., Ltd. and Cantel Medical (acquired by STERIS) among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Get PDF Report for Competitive Analysis:

https://meditechinsights.com/dialysis-market/request-sample/ 

Global Dialysis Market Segmentation

This report by Medi-Tech Insights provides the size of the global dialysis market at the regional- and country level from 2023 to 2030. The report further segments the market based on product & service, dialysis type, and end-user.

  • Market Size & Forecast (2023-2030), By Product & Service, USD Million
    • Device
      • Machine
      • Dialyzers
      • Water Treatment System
      • Others
    • Consumables
      • Bloodlines
      • Concentrates
      • Catheters
      • Others
    • Services
  • Market Size & Forecast (2023-2030), By Dialysis Type, USD Million
    • Hemodialysis
      • Conventional Hemodialysis
      • Short Daily Hemodialysis
      • Nocturnal Hemodialysis
    • Peritoneal Dialysis
      • Continuous Ambulatory Peritoneal Dialysis (CAPD)
      • Automated Peritoneal Dialysis (APD)
  • Market Size & Forecast (2023-2030), By End-user, USD Million
    • Hospitals
    • Home Care
    • Others
  • Market Size & Forecast (2023-2030), By Region, USD Million
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 
info@meditechinsights.com 

Comments

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...

Global Structural Heart Devices Market growth 9% CAGR with favorable reimbursement scenarios 2030

  The global structural heart devices market is set to witness a CAGR of ~9% in the next 5 years.  The rising geriatric population & corresponding rise in the prevalence of heart disease, technological advancements in structural heart devices, regulatory approval for expanded indications for several transcatheter heart valves, and increasing awareness and favorable reimbursements for these procedures in key markets are some of the pivotal factors driving the growth of the structural heart devices market. However, high device costs, complex procedures, and stringent regulatory hurdles continue to restrain market uptake.  Structural heart disease occurs when something is wrong with one’s heart valves, walls, chambers or muscles. It exists from birth or develops as one age. It includes conditions such as congenital heart disease, cardiomyopathy, and heart valve disease. Heart valve devices, occluders & delivery systems, annuloplasty rings, heart access systems, cl...